Data from Australian researchers could partly explain why a trial of a new drug for diabetes, was recently halted because it was found to be so effective.
US DoD grants $2.3m to Immuron for military version of anti-diarrhoeal Travelan – Pharmaceutical Technology
The DoD states that infectious diarrhoea is the most common illness that US troops deployed overseas experience. Image credit: Shutterstock / Andrew Angelov. Immuron Limited